Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

The Safety and Efficacy of Chronic Weekly Rozanolixizumab Treatment in Patients with Generalized Myasthenia Gravis (MG0004)

Author:Bril, Vera   Druzdz, Artur   Grosskreutz, Julian   Habib, Ali A.   Kaminski, Henry J.   Mantegazza, Renato   Sacconi, Sabrina   Utsugisawa, Kimiaki   Vu, Tuan   Boehnlein, Marion   Woltering, Franz   Greve, Bernhard   Gayfieva, Maryam   Vissing, John   

Session Name:P4: Autoimmune Neurology: Peripheral Autoimmunity  

Topic:Autoimmune Neurology  

Program Number:P4.017  

Author Institution:University Health Network, Toronto, ON, Canada, Toronto, ON, Canada  Department of Neurology, Municipal Hospital, Poznan, Poland, Swarzedz, Poland  Precision Neurology, Department of Neurology, University of Lübeck, Lübeck, Germany, Lubeck, Germany  MDA ALS and Neuromuscular Center, University of California, Irvine, Irvine, CA, USA, Orange, CA  Department of Neurology & Rehabilitation Medicine, George Washington University, Washington, DC, USA, Washington, DC  Department of Neuroimmunology and Neuromuscular Diseases, Fondazione IRCCS, Istituto Nazionale Neurologico Carlo Besta, Milan, Italy, Milan, Italy  Université Côte d’Azur, Peripheral Nervous System & Muscle Department, Pasteur 2 Hospital, Centre Hospitalier Universitaire de Nice, Nice, France, Nice, France  Department of Neurology, Hanamaki General Hospital, Hanamaki, Japan, Hanamaki, Japan  Department of Neurology, University of South Florida Morsani College of Medicine, Tampa, FL, USA, Tampa, FL  UCB Pharma, Monheim, Germany, Monheim, Germany  UCB Pharma, Monheim, Germany, Monheim Am Rhein, Germany  UCB Pharma, Slough, UK, London, United Kingdom  Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark, Copenhagen, Denmark  

Drivers of New Rozanolixizumab Treatment Cycles in Patients with Generalized Myasthenia Gravis in the Phase 3 MycarinG and Open-label Extension Studies

Author:Mahuwala, Zabeen K.   Grosskreutz, Julian   Habib, Ali A.   Mantegazza, Renato   Pascuzzi, Robert M.   Sacconi, Sabrina   Vissing, John   Vu, Tuan   Beau-Lejdstrom, Raphaelle   Greve, Bernhard   Grimson, Fiona   Tarancón, Thaïs   Bril, Vera   

Session Name:P10: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 3  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P10.003  

Author Institution:Department of Neuromuscular Medicine, Epilepsy and Clinical Neurophysiology, University of Kentucky, Lexington, KY, USA, LEXINGTON, KY  Precision Neurology, Department of Neurology, University of Lübeck, Lübeck, Germany, Lübeck, Germany  MDA ALS and Neuromuscular Center, University of California, Irvine, Irvine, CA, USA, Orange, CA  Department of Neuroimmunology and Neuromuscular Diseases, Fondazione IRCCS, Istituto Nazionale Neurologico Carlo Besta, Milan, Italy, Milan, Italy  Neurology Department, Indiana University School of Medicine, Indiana University Health, Indianapolis, IN, USA, Indianapolis, IN  Université Côte d'Azur, Peripheral Nervous System & Muscle Department, Pasteur 2 Hospital, Centre Hospitalier Universitaire de Nice, Nice, France, Nice, France  Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark, Copenhagen, Denmark  Department of Neurology, University of South Florida Morsani College of Medicine, Tampa, FL, USA, Tampa, FL  UCB Pharma, Bulle, Switzerland, Bulle, Switzerland  UCB Pharma, Monheim, Germany, Monheim, Germany  UCB Pharma, Slough, UK, London, United Kingdom  UCB Pharma, Madrid, Spain, Madrid, Spain  University Health Network, Toronto, ON, Canada, Toronto, ON, Canada  

Response to Rozanolixizumab Across Treatment Cycles in Patients with Generalized Myasthenia Gravis: A Post-hoc Analysis

Author:Pascuzzi, Robert M.   Grosskreutz, Julian   Habib, Ali A.   Mahuwala, Zabeen K.   Mantegazza, Renato   Sacconi, Sabrina   Vissing, John   Vu, Tuan   Beau Lejdstrom, Rapha?lle   Greve, Bernhard   Grimson, Fiona   Tarancón, Thaïs   Bril, Vera   

Session Name:P10: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 3  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P10.005  

Author Institution:Neurology Department, Indiana University School of Medicine, Indiana University Health, Indianapolis, IN, USA, Indianapolis, IN  Precision Neurology, Department of Neurology, University of Lübeck, Lübeck, Germany, Lübeck, Germany  MDA ALS and Neuromuscular Center, University of California, Irvine, Irvine, CA, USA, Orange, CA  Department of Neuromuscular Medicine and Clinical Neurophysiology, University of Kentucky, Lexington, KY, USA, Lexington, KY  Department of Neuroimmunology and Neuromuscular Diseases, Fondazione IRCCS, Istituto Nazionale Neurologico Carlo Besta, Milan, Italy, Milan, Italy  Université Côte d'Azur, Peripheral Nervous System & Muscle Department, Pasteur 2 Hospital, Centre Hospitalier Universitaire de Nice, Nice, France, Nice, France  Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark, Copenhagen, Denmark  Department of Neurology, University of South Florida Morsani College of Medicine, Tampa, FL, USA, Tampa, FL  UCB Pharma, Bulle, Switzerland, Bulle, Switzerland  UCB Pharma, Monheim, Germany, Monheim, Germany  UCB Pharma, Slough, UK, Slough, United Kingdom  UCB Pharma, Madrid, Spain, Madrid, Spain  University Health Network, Toronto, ON, Canada, Toronto, ON, Canada